Ifp Advisors, Inc Sanofi Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Sanofi stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,132 shares of SNY stock, worth $126,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,132

Previous 1,819 17.21%

Holding current value

$126,321

Previous $104,000 1.92%

% of portfolio

0.0%

Previous 0.0%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$45.89 - $57.31 $14,363 - $17,938	313 Added 17.21%	2,132 $102,000
Q3 2024 Feb 04, 2025	SELL	$48.54 - $58.53 $24,270 - $29,265	-500 Reduced 21.56%	1,819 $104,000
Q2 2024 Jul 30, 2024	BUY	$45.39 - $50.36 $17,838 - $19,791	393 Added 20.4%	2,319 $112,000
Q1 2024 Jul 30, 2024	SELL	$45.75 - $52.48 $7,640 - $8,764	-167 Reduced 7.98%	1,926 $93,000
Q4 2023 Jan 09, 2024	SELL	$43.13 - $54.79 $31,355 - $39,832	-727 Reduced 25.78%	2,093 $104,000
Q3 2023 Oct 12, 2023	BUY	$50.95 - $55.2 $58,286 - $63,148	1,144 Added 68.26%	2,820 $151,000
Q2 2023 Aug 04, 2023	BUY	$50.45 - $57.18 $5,448 - $6,175	108 Added 6.89%	1,676 $90,000
Q1 2023 Apr 18, 2023	SELL	$45.86 - $54.45 $151,108 - $179,412	-3,295 Reduced 67.76%	1,568 $85,000
Q4 2022 Feb 07, 2023	SELL	$38.86 - $48.55 $70,997 - $88,700	-1,827 Reduced 27.31%	4,863 $193,000
Q3 2022 Nov 08, 2022	BUY	$37.22 - $100.5 $6,662 - $17,989	179 Added 2.75%	6,690 $267,000
Q2 2022 Sep 06, 2022	BUY	$48.99 - $57.46 $318,973 - $374,122	6,511 New	6,511 $256,000
Q2 2022 Aug 12, 2022	SELL	$48.99 - $57.46 $318,973 - $374,122	-6,511 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$48.48 - $53.65 $173,509 - $192,013	3,579 Added 122.07%	6,511 $334,000
Q1 2022 Aug 08, 2022	BUY	$48.48 - $53.65 $8,144 - $9,013	168 Added 6.08%	2,932 $150,000
Q4 2021 Jan 12, 2022	SELL	$47.07 - $52.35 $46,175 - $51,355	-981 Reduced 26.19%	2,764 $140,000
Q3 2021 Oct 06, 2021	BUY	$47.89 - $53.12 $61,921 - $68,684	1,293 Added 52.73%	3,745 $180,000
Q2 2021 Jul 13, 2021	SELL	$49.36 - $54.25 $4,639 - $5,099	-94 Reduced 3.69%	2,452 $131,000
Q1 2021 Apr 30, 2021	SELL	$45.46 - $50.51 $16,229 - $18,032	-357 Reduced 12.3%	2,546 $127,000
Q4 2020 Jan 25, 2021	SELL	$45.3 - $51.62 $4,937 - $5,626	-109 Reduced 3.62%	2,903 $142,000
Q3 2020 Oct 29, 2020	BUY	$49.47 - $53.77 $4,353 - $4,731	88 Added 3.01%	3,012 $151,000
Q2 2020 Aug 05, 2020	SELL	$42.91 - $52.5 $7,294 - $8,925	-170 Reduced 5.49%	2,924 $148,000
Q1 2020 May 12, 2020	BUY	$38.02 - $51.66 $26,652 - $36,213	701 Added 29.29%	3,094 $132,000
Q4 2019 Jan 17, 2020	SELL	$44.25 - $50.86 $11,770 - $13,528	-266 Reduced 10.0%	2,393 $121,000
Q3 2019 Nov 07, 2019	SELL	$40.34 - $46.64 $4,397 - $5,083	-109 Reduced 3.94%	2,659 $121,000
Q1 2019 May 15, 2019	SELL	$40.83 - $45.43 $168,260 - $187,217	-4,121 Reduced 59.82%	2,768 $121,000
Q4 2018 Jan 23, 2019	SELL	$41.48 - $45.59 $51,061 - $56,121	-1,231 Reduced 15.16%	6,889 $299,000
Q3 2018 Oct 25, 2018	SELL	$40.0 - $44.84 $54,920 - $61,565	-1,373 Reduced 14.46%	8,120 $0
Q2 2018 Aug 07, 2018	SELL	$37.63 - $41.22 $62,390 - $68,342	-1,658 Reduced 14.87%	9,493 $0
Q1 2018 Jun 03, 2019	BUY	$38.98 - $45.76 $18,905 - $22,193	485 Added 4.55%	11,151 $479,000
Q1 2018 May 09, 2018	SELL	$38.98 - $45.76 $18,905 - $22,193	-485 Reduced 4.35%	10,666 $0
Q4 2017 Jan 24, 2018	SELL	$42.86 - $50.61 $198,613 - $234,526	-4,634 Reduced 29.36%	11,151 $0
Q3 2017 Oct 30, 2017	SELL	$47.04 - $50.34 $39,325 - $42,084	-836 Reduced 5.03%	15,785 $786,000
Q2 2017 Jun 03, 2019	BUY	N/A	304 Added 1.86%	16,621 $796,000
Q1 2017 Jun 03, 2019	SELL	N/A	-1,165 Reduced 6.66%	16,317 $738,000
Q4 2016 Jun 03, 2019	BUY	N/A	736 Added 4.4%	17,482 $707,000
Q2 2016 Jun 03, 2019	BUY	N/A	13,978 Added 504.99%	16,746 $701,000
Q1 2016 Jun 03, 2019	BUY	N/A	2,768	2,768 $121,000

Others Institutions Holding SNY

# of Institutions

804

Shares Held

266M

Call Options Held

1.82M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $149B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account